Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Fagan

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Applied Physiology (Bethesda, Md. : 1985)|May 18, 2001
Selected Contribution: Pulmonary hypertension in mice following intermittent hypoxiaK A Fagan
High Altitude Medicine & Biology|July 10, 2001
Potential genetic contributions to control of the pulmonary circulation and ventilation at high altitudeK A Fagan, J V Weil
Journal of Medical Genetics|December 1, 1989
Del(4)(q33----qter): another case report of a child with mild dysmorphismK A Fagan, R B Morris
The Journal of Biological Chemistry|May 24, 1996
Functional co-localization of transfected Ca(2+)-stimulable adenylyl cyclases with capacitative Ca2+ entry sitesK A Fagan, R Mahey, D M Cooper
The Journal of Biological Chemistry|May 16, 1998
Dependence of the Ca2+-inhibitable adenylyl cyclase of C6-2B glioma cells on capacitative Ca2+ entryK A Fagan, N Mons, D M Cooper
Physiological Research|February 24, 2001
Nitric oxide synthase in pulmonary hypertension: lessons from knockout miceK A Fagan, I McMurtry, D M Rodman
The Journal of Biological Chemistry|June 14, 2000
Regulation of the Ca2+-inhibitable adenylyl cyclase type VI by capacitative Ca2+ entry requires localization in cholesterol-rich domainsK A Fagan, K E Smith, D M Cooper
Respiratory Research|November 1, 2001
Role of endothelin-1 in lung diseaseK A Fagan, I F McMurtry, D M Rodman
FEBS Letters|July 4, 2001
Adenovirus encoded cyclic nucleotide-gated channels: a new methodology for monitoring cAMP in living cellsK A Fagan, J Schaack, A Zweifach, et al.
British Journal of Pharmacology|June 10, 2008
Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertensionM Oka, K A Fagan, P L Jones, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Applied Physiology (Bethesda, Md. : 1985)|May 18, 2001
Selected Contribution: Pulmonary hypertension in mice following intermittent hypoxiaK A Fagan
High Altitude Medicine & Biology|July 10, 2001
Potential genetic contributions to control of the pulmonary circulation and ventilation at high altitudeK A Fagan, J V Weil
Journal of Medical Genetics|December 1, 1989
Del(4)(q33----qter): another case report of a child with mild dysmorphismK A Fagan, R B Morris
The Journal of Biological Chemistry|May 24, 1996
Functional co-localization of transfected Ca(2+)-stimulable adenylyl cyclases with capacitative Ca2+ entry sitesK A Fagan, R Mahey, D M Cooper
The Journal of Biological Chemistry|May 16, 1998
Dependence of the Ca2+-inhibitable adenylyl cyclase of C6-2B glioma cells on capacitative Ca2+ entryK A Fagan, N Mons, D M Cooper
Physiological Research|February 24, 2001
Nitric oxide synthase in pulmonary hypertension: lessons from knockout miceK A Fagan, I McMurtry, D M Rodman
The Journal of Biological Chemistry|June 14, 2000
Regulation of the Ca2+-inhibitable adenylyl cyclase type VI by capacitative Ca2+ entry requires localization in cholesterol-rich domainsK A Fagan, K E Smith, D M Cooper
Respiratory Research|November 1, 2001
Role of endothelin-1 in lung diseaseK A Fagan, I F McMurtry, D M Rodman
FEBS Letters|July 4, 2001
Adenovirus encoded cyclic nucleotide-gated channels: a new methodology for monitoring cAMP in living cellsK A Fagan, J Schaack, A Zweifach, et al.
British Journal of Pharmacology|June 10, 2008
Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertensionM Oka, K A Fagan, P L Jones, et al.
Pageof 3